|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.54 INR | -1.39% |
|
-9.59% | -35.92% |
| Market Cap | 98Cr 1.01Cr 88.63L 82.33L 75.72L 1.42Cr 1.45Cr 9.85Cr 3.84Cr 48Cr 3.78Cr 3.7Cr 165.13Cr | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 134.42Cr 1.39Cr 1.22Cr 1.13Cr 1.04Cr 1.96Cr 1.99Cr 14Cr 5.29Cr 66Cr 5.21Cr 5.1Cr 227.46Cr | EV / Sales 2024 |
1,23,82,225x | EV / Sales 2025 | 1,42,98,457x |
| Free-Float |
21.42% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.39% | ||
| 1 week | -9.59% | ||
| Current month | -21.63% | ||
| 1 month | -8.10% | ||
| 3 months | -1.42% | ||
| 6 months | -30.98% | ||
| Current year | -35.92% |
| 1 week | 29.12 |  | 35.39 |
| 1 month | 29.12 | | 41.9 |
| Current year | 25.6 | | 50.9 |
| 1 year | 25.6 | | 69.9 |
| 3 years | 25.6 | | 87.46 |
| 5 years | 10.17 | | 87.46 |
| 10 years | 2.15 | | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 13/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 07/08/2025 | |
| Compliance Officer | - | 14/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 05/12/2025 | |
| Director/Board Member | - | 29/08/2023 | |
| Chairman | 50 | 31/01/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.39% | -9.59% | -54.42% | -32.46% | 1.13Cr | |
| +1.97% | +2.53% | +52.73% | +156.66% | 1,03700Cr | |
| +1.42% | +4.96% | +54.39% | +52.34% | 62TCr | |
| +1.43% | +5.25% | +37.31% | +78.74% | 45TCr | |
| +5.14% | +5.84% | +37.54% | +27.28% | 33TCr | |
| +1.85% | +4.64% | +38.53% | +39.87% | 29TCr | |
| -0.11% | +0.97% | +22.57% | +17.81% | 26TCr | |
| +0.25% | -3.10% | -24.44% | -42.25% | 22TCr | |
| +1.49% | +3.68% | +21.53% | +58.21% | 20TCr | |
| +0.40% | -0.64% | +18.78% | +62.28% | 16TCr | |
| Average | +1.25% | +0.18% | +20.45% | +41.85% | 35.57TCr | |
| Weighted average by Cap. | +1.73% | +1.47% | +38.33% | +75.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.56 1.37 1.28 1.17 2.2 2.24 15.25 5.95 73.71 5.86 5.73 255.72 | 195.14 2.01 1.77 1.65 1.51 2.84 2.89 19.69 7.68 95.18 7.56 7.4 330.2 |
| Net income | -7.97Cr -8L -7L -7L -6L -11.6L -11.8L -80.39L -31.36L -3.89Cr -30.89L -30.22L -13Cr | -11Cr -11.13L -10L -9L -8L -15.68L -15.96L -1.09Cr -42.41L -5.26Cr -41.78L -40.87L -18Cr |
| Net Debt | 3.73Cr 4L 3L 3L 3L 5L 6L 37.62L 14.67L 1.82Cr 14.46L 14.14L 6.31Cr | 37Cr 38.03L 33.45L 31.07L 28.58L 53.6L 54.56L 3.72Cr 1.45Cr 18Cr 1.43Cr 1.4Cr 62Cr |
Employees
28
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | ₹30.54 | -1.39% | 3,840 |
| 22/26/22 | ₹30.97 | -0.19% | 3,074 |
| 21/26/21 | ₹31.03 | +0.13% | 5,991 |
| 20/26/20 | ₹30.99 | -6.09% | 9,561 |
| 17/26/17 | ₹33.00 | -0.51% | 6,578 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
